APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 42 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $212,000 | +60.6% | 50,700 | -5.1% | 0.01% | +11.1% |
| Q4 2018 | $132,000 | -80.8% | 53,400 | -43.3% | 0.01% | -76.9% |
| Q3 2018 | $686,000 | +119.2% | 94,100 | +11.1% | 0.04% | +116.7% |
| Q2 2018 | $313,000 | -4.0% | 84,700 | 0.0% | 0.02% | -14.3% |
| Q1 2018 | $326,000 | -15.8% | 84,700 | -21.4% | 0.02% | 0.0% |
| Q4 2017 | $387,000 | +102.6% | 107,700 | +122.1% | 0.02% | +110.0% |
| Q3 2017 | $191,000 | -85.4% | 48,500 | -63.8% | 0.01% | -90.6% |
| Q3 2016 | $1,310,000 | -30.6% | 134,000 | +0.3% | 0.11% | -39.8% |
| Q2 2016 | $1,887,000 | +35.2% | 133,600 | +33.7% | 0.18% | +24.8% |
| Q1 2016 | $1,396,000 | -16.0% | 99,900 | +22.6% | 0.14% | -33.5% |
| Q4 2015 | $1,662,000 | +48.0% | 81,500 | -4.8% | 0.21% | +45.2% |
| Q3 2015 | $1,123,000 | +488.0% | 85,600 | +731.1% | 0.15% | +403.4% |
| Q3 2014 | $191,000 | – | 10,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |